Leaflet: information for the user
Ideos 500 mg/2,000 IU chewable tablets
calcium/colecalciferol (vitamin D3)
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
Ideos is a calcium and vitamin D supplement3.
It is used
Do not take Ideos
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication:
Children and adolescents
This medication is not indicated for use in children and adolescents.
Other medications and Ideos
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medication.
If you are taking any of the medications mentioned above, your doctor will give you further instructions.
Taking Ideos with food, drinks, and alcohol
You can take the medication at any time, with or without food.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medication.
This medication is not recommended for use during pregnancy in patients who do not have calcium and vitamin D deficiency. When there is a vitamin D deficiency, the recommended daily dose depends on national guidelines; however, the maximum daily dose should not exceed 2,500 mg of calcium and 4,000 IU of vitamin D per day.
Prolonged overdose of calcium and vitamin D during pregnancy should be avoided, as this can lead to high levels of calcium in the blood and may have a negative effect on the fetus.
This medication can be used during breastfeeding. Since calcium and vitamin D pass into breast milk, consult your doctor first if your child is receiving other products that contain vitamin D. This should be taken into account when administering additional vitamin D to the child.
Alternatively, the treatment can be changed to other medications that contain calcium and vitamin D3with lower concentrations of vitamin D3.
Driving and operating machinery
This medication has no effect on your ability to drive and use machines.
This medication contains
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The recommended dose is 1 chewable tablet per day, corresponding to 500 mg of calcium and 2,000 IU (International Units) of vitamin D3. Your doctor will decide on the dosage individually.3
The tablet should be chewed before swallowing. It can be taken at any time, with or without food.
Be sure to pay attention to a daily sufficient intake of calcium through nutrition (i.e., dairy products, vegetables, mineral water).
Use in children and adolescents
This medicationis not intendedfor use in children and adolescents.
If you take more Ideos than you should
Overdosing on this medication may cause symptoms such as discomfort (nausea), vomiting, thirst or excessive thirst, increased urine production, dehydration, or constipation. If you suspect an overdose, contact your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Ideos
If you forget to take this medication, take it as soon as you remember. However, do not take a double dose to compensate for the missed tablets.
If you interrupt treatment with Ideos
If you wish to interrupt or prematurely discontinue treatment, consult your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not all people may experience them.
Stop taking Ideos and contact a doctor immediatelyif you experience the following allergic reaction (of unknown frequency because it cannot be estimated from the available data):
- Swelling of the face, lips, tongue, or throat with sudden difficulty breathing and skin rashserious.
The other reported adverse effects are:
Rarely:may affect up to 1 in 100 people
Very Rare:may affect up to 1 in 1,000 people
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and on the laminated aluminum foil strips after “CAD”. The expiration date is the last day of the month indicated.
This medication does not require any special storage temperature. Keep the container perfectly closed to protect it from moisture.
Medications should not be disposed of through drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Appearance of the product and contents of the package
The chewable tablets are round, white, 18 mm in diameter.
It is available in polypropylene tubes with a polyethylene cap that contains a desiccant or in laminated aluminum paper strips. Break the strip to open it.
Package sizes:
Tubes: 30, 60 (2x30) and 90 (3x30) chewable tablets.
Strips: 30 (5x6), 60 (10x6), 90 (15x6) chewable tablets.
Only some package sizes may be commercially available.
Holder of the marketing authorization
Theramex Ireland Limited
3rd Floor, Kilmore House,
Park Lane, Spencer Dock,
Dublin 1
D01 YE64
Ireland
Responsible for manufacturing
HERMESPHARMAGmbH
Hans-Urmiler-Ring 52
82515Wolfratshausen
Germany
You can request more information about this medication by contacting the local representative of the holder of the marketing authorization
Theramex Healthcare Spain, S.L.
Calle Martínez Villergas 52, Edificio C, 2nd floor left.
28027 Madrid
Spain
This medication is authorized in the member states of the European Economic Area with the following names:
Belgium:Calcium/Vitamin D3 Theramex 500 mg/2000 UI chewable tablets
Calcium/Vitamin D3 Theramex 500 mg/2000 IE chewable tablets
Calcium/Vitamin D3 Theramex 500 mg/2000 IE chewable tablets
Spain:Ideos 500 mg/2,000 UI chewable tablets
Portugal:Cacit 500 mg / 2000 UI chewable tablets
Sweden:Calcium/Cholecalciferol Theramex
Date of the last review of this prospectus:23 February 2024
The detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.